Li-Ju Chang

Specialist/Regulatory Toxicologist at Efficient Pharma Management Corp., Taiwan

PEMM Class of 2011

Selected Publications

  • Chang LJ, Eastman A. Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications. Cancer Biol Ther. 2012; 13(11):1047-57.

  • Chang LJ, Eastman A. Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors. Cell Cycle. 2012; 11(9):1818-26.